hummingbird's MRI Brain History

hummingbird: Sex: F; Data Quality: 3 stars; MS: 22 yrs; Type: Relapsing-Remitting; Sensation: Moderate; Overall: Mild; Cognition: moderate; Vision: moderate; Speech: mild; Swallowing: none; Upper limb: none; Walking: none

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

hummingbird's MRI Brain is for:

hummingbird's MRI Brain History (Ongoing)
MRI Brain (mri)
One time Dec 13 - 13, 2005
One time Jun 01 - 01, 2006
One time May 14, 2007 - May 30, 2008
One time May 30, 2008 - Jan 31, 2009
One time Oct 29, 2010 - Last Update
Stopped Other Dec 13, 2005
Stopped Other Dec 13, 2005
Stopped Other Jun 01, 2006
Stopped Course of treatment ended Jan 31, 2009

Evaluations
Date	Dosage	MS (Multiple Sclerosis) Efficacy	Side Effects	Adherence	Burden
Nov 02, 2010	One time
Jan 31, 2009	One time

Date: Nov 02, 2010
Advice & Tips: I had an MRI with contrast on Oct 29th 2010. The following day I was unusually tired. I wondered if the gadolinium used for the contrast caused my unwillingness to get out of bed.
Cost: $200+ monthly

Date: Jan 31, 2009
Advice & Tips: I was in the ASSERT study, which ended a year early. I was in the Copaxone + high dose oral steroid arm. The prednisone dose was 1250mg for 5 days in a row every 4 months. I took all the prednisone as directed, but missed some Copaxone injections. I found that at the end of 4 months I was dragging, then I took the prednisone for 5 days. I would generally feel bad for 1 week after the steroids, but that got better with each pulse. Then I would have a normal energy level for quite some time, so the negative factors were outweighed by the positive. The ASSERT study ended early because there was no effect seen with the steroid arm, thats what they say. The nurse said that so many people lost jobs and their insurance they could not afford the Copaxone and dropped out of the study. **Advice: if you are going to commit to a study, the study drug should be provided at no cost to you. In ASSERT prednisone was labelled the study drug**
Cost: $200+ monthly